The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective pilot study of pharmacogenetic-based dosing of 5-fluouracil (5-FU) and irinotecan (IRI) in patients (pts) with gastrointestinal (GI) malignancies.
 
Jeffrey Chi
No Relationships to Disclose
 
Nausheen Hakim
No Relationships to Disclose
 
Hasan Rehman
No Relationships to Disclose
 
Linda Moriarty
No Relationships to Disclose
 
Antonia Maloney
No Relationships to Disclose
 
Melissa H Smith
No Relationships to Disclose
 
Jyothi Jose
No Relationships to Disclose
 
Wasif M. Saif
Consulting or Advisory Role - Celgene
Speakers' Bureau - Amgen; Celgene; Genentech; Ipsen; Lexicon; Novartis; Taiho Pharmaceutical
Research Funding - Celgene (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); Lexicon; NanoCarrier; Pharmacyclics; Taiho Pharmaceutical (Inst)